|
1
|
Silvestri GA and Rivera MP: Targeted
therapy for the treatment of advanced non-small cell lung cancer: A
review of the epidermal growth factor receptor antagonists. Chest.
128:3975–3984. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Recchi C and Seabra MC: Novel functions
for Rab GTPases in multiple aspects of tumor progression. Biochem
Soc Trans. 40:1398–1403. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Osanai K and Voelker DR: Analysis and
expression of Rab38 in oculocutaneous lung disease. Methods
Enzymol. 438:203–215. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
MAQC Consortium, ; Shi L, Reid LH, Jones
WD, Shippy R, Warrington JA, Baker SC, Collins PJ, de Longueville
F, Kawasaki ES, et al: The MicroArray Quality Control (MAQC)
project shows interplatform reproducibility of gene expression
measurements. Nat Biotechnol. 24:1151–1161. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ho JR, Chapeaublanc E, Kirkwood L, Nicolle
R, Benhamou S, Lebret T, Allory Y, Southgate J, Radvanyi F and Goud
B: Deregulation of Rab and Rab effector genes in bladder cancer.
PLoS One. 7:e394692012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dong W, Cui J, Yang J, Li W, Wang S, Wang
X, Li X, Lu Y and Xiao W: Decreased expression of Rab27A and Rab27B
correlates with metastasis and poor prognosis in colorectal cancer.
Discov Med. 20:357–367. 2015.PubMed/NCBI
|
|
7
|
He H, Dai F, Yu L, She X, Zhao Y, Jiang J,
Chen X and Zhao S: Identification and characterization of nine
novel human small GTPases showing variable expressions in liver
cancer tissues. Gene Expr. 10:231–242. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shimada K, Uzawa K, Kato M, Endo Y, Shiiba
M, Bukawa H, Yokoe H, Seki N and Tanzawa H: Aberrant expression of
RAB1A in human tongue cancer. Br J Cancer. 92:1915–1921. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Culine S, Honore N, Closson V, Droz JP,
Extra JM, Marty M, Tavitian A and Olofsson B: A small GTP-binding
protein is frequently overexpressed in peripheral blood mononuclear
cells from patients with solid tumours. Eur J Cancer 30A. 670–674.
1994. View Article : Google Scholar
|
|
10
|
Amillet JM, Ferbus D, Real FX, Antony C,
Muleris M, Gress TM and Goubin G: Characterization of human Rab20
overexpressed in exocrine pancreatic carcinoma. Hum Pathol.
37:256–263. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kotzsch M, Sieuwerts AM, Grosser M, Meye
A, Fuessel S, Meijer-van Gelder ME, Smid M, Schmitt M, Baretton G,
Luther T, et al: Urokinase receptor splice variant
uPAR-del4/5-associated gene expression in breast cancer:
Identification of rab31 as an independent prognostic factor. Breast
Cancer Res Treat. 111:229–240. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tan PY, Chang CW, Chng KR, Wansa KD, Sung
WK and Cheung E: Integration of regulatory networks by NKX3-1
promotes androgen-dependent prostate cancer survival. Mol Cell
Biol. 32:399–414. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mori Y, Yin J, Sato F, Sterian A, Simms
LA, Selaru FM, Schulmann K, Xu Y, Olaru A, Wang S, et al:
Identification of genes uniquely involved in frequent
microsatellite instability colon carcinogenesis by expression
profiling combined with epigenetic scanning. Cancer Res.
64:2434–2438. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shibata D, Mori Y, Cai K, Zhang L, Yin J,
Elahi A, Hamelin R, Wong YF, Lo WK, Chung TK, et al: RAB32
hypermethylation and microsatellite instability in gastric and
endometrial adenocarcinomas. Int J Cancer. 119:801–806. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zippelius A, Gati A, Bartnick T, Walton S,
Odermatt B, Jaeger E, Dummer R, Urosevic M, Filonenko V, Osanai K,
et al: Melanocyte differentiation antigen RAB38/NY-MEL-1 induces
frequent antibody responses exclusively in melanoma patients.
Cancer Immunol Immunother. 56:249–258. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang H and Jiang C: RAB38 confers a poor
prognosis, associated with malignant progression and subtype
preference in glioma. Oncol Rep. 30:2350–2356. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chang JW, Wei NC, Su HJ, Huang JL, Chen
TC, Wu YC, Yu CT, Hou MM, Hsieh CH, Hsieh JJ, et al: Comparison of
genomic signatures of non-small cell lung cancer recurrence between
two microarray platforms. Anticancer Res. 32:1259–1265.
2012.PubMed/NCBI
|
|
18
|
Jäger D, Stockert E, Jäger E, Güre AO,
Scanlan MJ, Knuth A, Old LJ and Chen YT: Serological cloning of a
melanocyte rab guanosine 5′-triphosphate-binding protein and a
chromosome condensation protein from a melanoma complementary DNA
library. Cancer Res. 60:3584–3591. 2000.PubMed/NCBI
|
|
19
|
Walton SM, Gerlinger M, de la Rosa O,
Nuber N, Knights A, Gati A, Laumer M, Strauss L, Exner C, Schäfer
N, et al: Spontaneous CD8 T cell responses against the melanocyte
differentiation antigen RAB38/NY-MEL-1 in melanoma patients. J
Immunol. 177:8212–8218. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen J, Wang M, Zu L, Li W, Wang W, Li Y
and Liu H: Abstract 4966: Establishment and characterization of a
paired human non-small cell lung cancer cell lines from primary
cancer and metastasis lymph node. Cancer Res. 74:2014.
|
|
21
|
Wu CY, Tseng RC, Hsu HS, Wang YC and Hsu
MT: Frequent down-regulation of hRAB37 in metastatic tumor by
genetic and epigenetic mechanisms in lung cancer. Lung Cancer.
63:360–367. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tzeng HT, Tsai CH, Yen YT, Cheng HC, Chen
YC, Pu SW, Wang YS, Shan YS, Tseng YL, Su WC, et al: Dysregulation
of Rab37-mediated cross-talk between cancer cells and endothelial
cells via thrombospondin-1 promotes tumor neovasculature and
metastasis. Clin Cancer Res. 23:2335–2345. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Subramani D and Alahari SK:
Integrin-mediated function of Rab GTPases in cancer progression.
Mol Cancer. 9:3122010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Huck L, Pontier SM, Zho DM and Muller WJ:
Beta1-integrin is dispensable for the induction of ErbB2 mammary
tumors but plays a critical role in the metastatic phase of tumor
progression. Proc Natl Acad Sci USA. 107:15559–15564. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Morello V, Cabodi S, Sigismund S,
Camacho-Leal MP, Repetto D, Volante M, Papotti M, Turco E and
Defilippi P: β1 integrin controls EGFR signaling and tumorigenic
properties of lung cancer cells. Oncogene. 30:4087–4096. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jeong BY, Cho KH, Jeong KJ, Park YY, Kim
JM, Rha SY, Park CG, Mills GB, Cheong JH and Lee HY: Rab25 augments
cancer cell invasiveness through aβ1 integrin/EGFR/VEGF-A/Snail
signaling axis and expression of fascin. Exp Mol Med. 50:e4352018.
View Article : Google Scholar : PubMed/NCBI
|
